From: Renal function deterioration in adult patients with type-2 diabetes
 | Univariate frequency (95%CI) | Model 1 frequency (95%CI) | Model 2 frequency (95%CI) | p-value Model 2 |
---|---|---|---|---|
Microalbuminuria (%) | ||||
 eGFR-increasea > 12 | 42.3 (41.3–43.4) | 42.9 (41.7–44.1) | 42.8 (41.6–44.0) | < 0.001 |
 eGFR-increasea 0 up to + 12 | 40.4 (39.2–41.6) | 40.3 (39.1–41.5) | 40.3 (39.1–41.5) |  |
 eGFR-slopea 0 down to −12 | 41.8 (40.5–43.2) | 41.4 (40.1–42.8) | 41.3 (40.0–42.7) |  |
 eGFR-slopea -12 or smaller | 50.9 (49.7–52.0) | 49.4 (48.2–50.7) | 49.1 (47.9–50.4) |  |
Hypertension (%) | ||||
 eGFR-increasea > 12 | 83.6 (82.9–84.4) | 88.4 (87.7–89.1) | n.a. | 0.002b |
 eGFR-increasea 0 up to + 12 | 88.0 (87.3–88.8) | 89.0 (88.2–89.7) | n.a. |  |
 eGFR-slopea 0 down to −12 | 89.9 (89.2–90.7) | 89.9 (89.0–90.6) | n.a. |  |
 eGFR-slopea < −12 or smaller | 91.8 (91.3–92.4) | 90.4 (89.7–91.1) | n.a. |  |
Dyslipidemia (%) | ||||
 eGFR-increasea > 12 | 68.7 (67.7–69.6) | 70.7 (69.6–71.7) | 72.4 (71.3–73.4) | < 0.001 |
 eGFR-increasea 0 up to + 12 | 68.2 (67.1–69.2) | 68.2 (67.1–69.3) | 69.9 (68.8–71.0) |  |
 eGFR-slopea 0 down to −12 | 69.2 (68.0–70.4) | 69.0 (67.8–70.2) | 70.4 (69.2–71.6) |  |
 eGFR-slopea < −12 or smaller | 59.1 (58.1–60.2) | 58.9 (57.7–60.0) | 58.7 (57.5–60.0) |  |